Sumanth Daram, MD
Gastroenterology · Augusta, GANPI 1619957107
Payments from drug & device makers
Across 492 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Ovesco Endoscopy USA, Inc.$1K
- Johnson & Johnson$576
- Bristol Myers Squibb$408
- plus $3K from 24 others
What the payments were for
- Travel & lodging$1,01210%
- Food & beverage$8,77189%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 116 | $2,039 |
| Takeda Pharmaceuticals U.S.A., Inc. | 69 | $1,680 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 108 | $1,229 |
| Ovesco Endoscopy USA, Inc. | 1 | $1,012 |
| Johnson & Johnson | 28 | $576 |
| Bristol Myers Squibb | 23 | $408 |
| Ardelyx, Inc. | 18 | $383 |
| Merck | 14 | $283 |
| Redhill Biopharma Inc. | 22 | $276 |
| Ironwood Pharmaceuticals, Inc | 13 | $250 |
| Madrigal Pharmaceuticals | 13 | $216 |
| Medtronic | 3 | $196 |
| Lilly USA, LLC | 6 | $157 |
| Sanofi | 6 | $157 |
| Braintree Laboratories, Inc. | 7 | $131 |
| Conmed Corporation | 5 | $130 |
| Gilead | 6 | $119 |
| Evoke Pharma, Inc. | 6 | $117 |
| Pfizer | 7 | $114 |
| Phathom Pharmaceuticals, Inc. | 3 | $90 |
| Intercept Pharmaceuticals, Inc. | 3 | $59 |
| Boston Scientific | 2 | $52 |
| Novo Nordisk | 2 | $41 |
| Exact Sciences | 2 | $39 |
| Fujifilm Healthcare Americas Corporation | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Cook Medical LLC | 2 | $25 |
| Axonics, Inc. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Gastrogpo, LLC | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPOWDER$139
How this compares
$9,865 in reported general payments places this provider in the 75th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 28 | $73,144 |
| LinzessLinaclotide | 86 | $69,673 |
| XifaxanRifaximin | 16 | $54,479 |
| TrulancePlecanatide | 36 | $30,089 |
| IbsrelaTenapanor Hcl | 11 | $22,653 |
| MotegrityPrucalopride Succinate | 28 | $19,036 |
| Sucralfate | 106 | $12,076 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 56 | $7,968 |
| MovantikNaloxegol Oxalate | 13 | $7,518 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 47 | $5,846 |
| Dexlansoprazole DrDexlansoprazole | 23 | $5,776 |
| Lactulose | 139 | $5,190 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 26 | $4,154 |
| Pantoprazole Sodium | 385 | $3,851 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 55 | $3,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,039 | $142,817114 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu | $1,229 | $92,536108 claims |
| Ardelyx, Inc.Ibsrela | $383 | $22,65311 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,680 | $19,03628 claims |
| Braintree Laboratories, Inc.Suflave, Sutab | $131 | $10,00173 claims |
| Redhill Biopharma Inc.Movantik | $276 | $7,51813 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $12 | $2,92117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Augusta
- Satish RaoAugusta$397K
- Kenneth VegaAugusta$106K
- Bryan CurtinAugusta$82K
- Sunil LalAugusta$26K
- Douglas WolfAtlanta$6.4M
- Aasim SheikhMarietta$6M
- Shahriar SedghiMacon$5.4M
- Jeffrey WilliamsAthens$2.5M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.